Filing Details
- Accession Number:
- 0001209191-15-048102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-29 19:27:43
- Reporting Period:
- 2015-05-27
- Filing Date:
- 2015-05-29
- Accepted Time:
- 2015-05-29 19:27:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1496268 | Reva Medical Inc. | RVA:AX | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 330810505 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1404477 | Bain Robert Thomas | 5751 Copley Drive San Diego CA 92111 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-05-27 | 15,000 | $0.00 | 15,000 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2015-05-28 | 10,000 | $3.85 | 55,000 | No | 4 | P | Indirect | Rob Thomas Superannuation Fund |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | P | Indirect | Rob Thomas Superannuation Fund |
Footnotes
- These restricted stock units vest in full on the earlier of (i) May 27, 2016 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting.
- Represents the purchase of 100,000 of the Company's Chess Depositary Interests (CDIs), trading on the Austrialian Securities Exchange.
- The purchase was executed in the form of CDIs, trading on the Austrialian Securities Exchange, and as such the purchase price has been converted to a USD equivalent, adjusting for the ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction.
- This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $3.75 to $3.91. The price reported in this column reflects the weighted average purchase price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.